Recruitment lecture 11.18.2019

Today's case was about an older patient with urothelial carcinoma on pembrolizumab (PD-1 checkpoint inhibitor) presenting with nausea, vomiting and decreased PO intake. DDx was complicated by the fact that they had CKD 5 not on dialysis (with acute mild worsening of his AKI) but they were ultimately diagnosed with PD-1 induced hypophysitis - rare … Continue reading Recruitment lecture 11.18.2019